Community Research and Development Information Service - CORDIS

Horizon 2020 project information and now also report summaries are available on CORDIS. All H2020 projects can be downloaded from the EU Open Data Portal .

My refinements

Download results of this page

Refine by:


Austria (2)
Belgium (7)
Burkina Faso (1)
Czech Republic (2)
Denmark (5)
Finland (3)
France (8)
Gabon (1)
Germany (10)
Greece (1)
Ireland (1)
Israel (1)
Italy (8)
Luxembourg (2)
Netherlands (10)
Portugal (1)
Senegal (1)
Spain (4)
Sweden (6)
Switzerland (6)
United Kingdom (15)
United States (7)

Content Type

Project (13)
Report Summary (6)
Programme (11)


English (30)

Advanced search

Results 1 - 10 of 30
12 3 > 
Periodic Reporting for period 1 - EBODAC (Communication strategy and tools for optimizing the impact of Ebola vaccination deployment.)
The Ebola virus disease (EVD) epidemic has infected more than 28.000 people and killed more than 11.000 from March 2014 to December 2015, the vast majority of them in 3 West African countries: Guinea, Liberia and Sierra Leone (WHO Ebola Situation Report June 10, 2016). No...
Programme: H2020-EU.
Record Number: 232106
Last updated on: 2018-06-22
Periodic Reporting for period 2 - EbolaMoDRAD (Ebola Virus: Modern Approaches for developing  bedside Rapid Diagnostics)
Within the second period of the project we have developed several assays and protocols, which will facilitate achievement of EbolaMODRAD overall goals. We have, among others, successfully developed an inactivation vacuum tubes, which not only contribute to a safer transfer and...
Programme: H2020-EU.
Record Number: 228373
Last updated on: 2018-05-10
Periodic Reporting for period 2 - EBOVAC2 (Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen: Phase II)
Combining the expertise and capabilities of global research institutions, non-government organizations and the pharmaceutical industry has been critical to help address the Ebola public health challenge.The Ebola vaccine projects - EBOVAC1, EBOVAC2, EBODAC and EBOMAN - are a...
Programme: H2020-EU.
Record Number: 230029
Last updated on: 2018-05-22
Periodic Reporting for period 2 - VSV-EBOVAC (Vaccine safety and immunogenicity signatures of human responses to VSV-ZEBOV)
"The overall objective of VSV-EBOVAC is to comprehensively characterize the immune and molecular signatures of immune responses elicited in humans by rVSV-ZEBOV, a promising Ebola vaccine candidate based on the replication-competent recombinant vesicular stomatitis virus (VSV)...
Programme: H2020-EU.
Record Number: 230741
Last updated on: 2018-05-31
Mobile Filovirus Nucleic Acid Test
ID: 115848
Start date: 2015-02-01, End date: 2017-04-30
We are proposing to develop a molecular assay for the safe, rapid, specific and sensitive detection of Ebola Virus Infection in capillary (or venous) blood samples combining ALTONA’s Pan-filo screening IVD test with the existing Alere™ q point of care molecular diagnostics...
Programme: H2020-EU.
Record Number: 209448
Last updated on: 2017-06-01
Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management
ID: 777365
Start date: 2017-09-01, End date: 2022-08-31
Drug safety assessment is a knowledge-intensive process that demands advancement in data handling methods and tools for facilitating data sharing, mining, analysis and predictive modelling. This need is not restricted to any specific type of data and real advancement...
Programme: H2020-EU.
Record Number: 212141
Last updated on: 2017-12-06
Vaccine safety and immunogenicity signatures of human responses to VSV-ZEBOV
ID: 115842
Start date: 2015-03-01, End date: 2018-02-28
The proposal, VSV-EBOVAC, directly addresses the topic 1 of the IMI2 call on Ebola by supporting the clinical development of a highly promising new Ebola vaccine candidate, the vesicular stomatitis virus (VSV)‐ vectored Zaire Ebola vaccine (VSV-ZEBOV). In non-human primates...
Programme: H2020-EU.
Record Number: 209443
Last updated on: 2017-06-10
Periodic Reporting for period 1 - ADAPT-SMART (Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes)
Progress in life sciences and related technologies offers the potential to bring a wide range of beneficial new therapies to patients over the coming years. There will be more personalised or stratified medicines, combinations, borderline products, and advanced therapies that...
Programme: H2020-EU.
Record Number: 228436
Last updated on: 2018-05-10
Periodic Reporting for period 1 - FILODIAG (Ultra-Fast Molecular Filovirus Diagnostics)
The aim of this project is to provide an ultra-fast and accurate molecular diagnostic platform that can perform a molecular test on the Ebola virus within 10-15 minutes. Patients, suspected of EVD, due to fever and/or other clinical signs, could be rapidly and accurately...
Programme: H2020-EU.
Record Number: 228432
Last updated on: 2018-05-10
Manufacturing and Development for Rapid Access Ebola Vaccine (EBOMAN)
ID: 115850
Start date: 2014-12-01, End date: 2017-11-30
This topic response (Topic 2: Manufacturing Capability) forms part of an integrated proposal to address the urgent unmet needs of accelerating the development of an Ebola vaccine. To help facilitate this main goal additional activities will be performed; the generation of...
Programme: H2020-EU.
Record Number: 209444
Last updated on: 2017-03-27
12 3 > 
List retrieved on: 2018-06-24
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top